Physician profile
Grace C Odi
NPI 1922398528
$14,392.67
in general payments reported to CMS, 2019-2025
64 companies · $2,238 in 2025
The $2,238 reported for 2025 was more than what 97% of Hospitalist providers received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,688 · 2020: $1,629 · 2021: $1,818 · 2022: $1,199 · 2023: $2,138 · 2024: $1,682 · 2025: $2,238.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,059.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,058.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,891.62 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Amgen INC. | $1,659.89 | 2019-2025 | Repatha, Evenity, Otezla |
| Lilly USA, LLC | $1,340.78 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Astrazeneca Pharmaceuticals LP | $1,233.41 | 2019-2025 | Farxiga, Airsupra |
| Pfizer INC. | $541.41 | 2019-2025 | |
| Abbvie INC. | $527.21 | 2019-2025 | |
| Corcept Therapeutics | $446.74 | 2022-2025 | Korlym |
| Sanofi-Aventis U.S. LLC | $441.70 | 2019-2025 | |
| Esperion Therapeutics, INC. | $430.20 | 2021-2024 | Nexletol |
| Mannkind Corporation | $397.79 | 2019-2025 | Afrezza |
| Boehringer Ingelheim Pharmaceuticals, INC. | $385.32 | 2019-2025 | Jardiance |
| Abbott Laboratories | $381.09 | 2022-2025 | Freestyle Libre 3, Thoratec Heartmate 3 Lvas Implant Kit |
| Radius Health, INC. | $293.84 | 2019-2025 | Tymlos |
| Amneal Pharmaceuticals LLC | $275.14 | 2019-2025 | Unithroid |
| Exact Sciences Corporation | $243.20 | 2023-2025 | Cologuard Collection Kit |
Show all 64 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $215.84 | 2019-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $197.39 | 2019-2025 | Xifaxan |
| Insulet Corporation | $187.73 | 2019-2025 | Omnipod |
| Ibsa Pharma INC. | $176.77 | 2019-2025 | Tirosint, Licart, Flector |
| Valeritas, INC. | $175.52 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $169.85 | 2019-2022 | |
| Inspire Medical Systems, INC. | $165.94 | 2023-2025 | Inspire |
| Vivus LLC | $165.32 | 2019-2022 | |
| Grt US Holding, INC. | $153.31 | 2021 | |
| Cequr Corporation | $147.96 | 2023-2025 | Cequr Simplicity |
| Glaxosmithkline, LLC. | $143.11 | 2022-2025 | Shingrix, Arexvy, Fluarix Quadrivalent |
| Amarin Pharma, INC. | $137.43 | 2019-2021 | |
| Tandem Diabetes Care, INC. | $132.66 | 2019-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Ascendis Pharma Endocrinology INC | $125.99 | 2023-2025 | Yorvipath |
| Bayer Healthcare Pharmaceuticals INC. | $123.48 | 2023-2025 | |
| Sanofi Pasteur INC. | $93.91 | 2023-2025 | |
| Tolmar, INC. | $93.27 | 2023-2025 | Jatenzo |
| Boston Scientific Corporation | $91.29 | 2019-2024 | Watchman Flx |
| Dexcom, INC. | $91.25 | 2019-2024 | Dexcom G6 Transmitter |
| Beta Bionics, INC. | $80.71 | 2023-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Arbor Pharmaceuticals, INC. | $76.08 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $70.96 | 2019 | |
| Xeris Pharmaceuticals, INC. | $70.26 | 2022-2024 | Gvoke Hypopen |
| Astellas Pharma US INC | $62.59 | 2022-2025 | Veozah |
| Biohaven Pharmaceuticals, INC. | $54.95 | 2021 | |
| Phadia US INC. | $52.75 | 2019 | |
| Merck Sharp & Dohme LLC | $47.47 | 2019-2020 | |
| Verity Pharmaceuticals INC. | $43.44 | 2025 | Tlando |
| Kyowa Kirin, INC. | $41.00 | 2024-2025 | Crysvita |
| Shire North American Group INC | $40.97 | 2019 | |
| Medtronic, INC. | $39.16 | 2022-2023 | Minimed 780g |
| Neurocrine Biosciences, INC. | $37.55 | 2025 | |
| Vertical Pharmaceuticals, LLC | $37.27 | 2019-2020 | |
| Madrigal Pharmaceuticals | $36.25 | 2025 | Rezdiffra |
| Ultragenyx Pharmaceutical INC. | $36.10 | 2019-2024 | Crysvita |
| Embecta Corp. | $27.52 | 2023 | Bd Nano 2nd Gen Pen Needle |
| Antares Pharma, INC. | $26.35 | 2022-2023 | Tlando, Xyosted, Nocdurna |
| Alexion Pharmaceuticals, INC. | $26.12 | 2025 | Strensiq |
| Dynavax Technologies Corporation | $25.41 | 2024 | Heplisav-B |
| Recordati_rare_diseases_inc. | $22.19 | 2025 | Isturisa |
| Horizon Therapeutics Plc | $22.17 | 2023 | Tepezza |
| Halozyme INC | $22.04 | 2023 | |
| Zealand Pharma US, INC. | $19.97 | 2021 | |
| Idorsia Pharmaceuticals US INC | $18.45 | 2023 | Quviviq |
| Ironwood Pharmaceuticals, INC | $18.12 | 2019 | |
| Ipsen Biopharmaceuticals, INC | $17.88 | 2022 | |
| Therapeuticsmd, INC. | $15.14 | 2019 | |
| Avanir Pharmaceuticals, INC. | $13.99 | 2019 | |
| Currax Pharmaceuticals LLC | $12.45 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Grace Odi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.